Perinatal Hepatitis B Prevention Program
This program provides support, education, and reminders to providers to ensure that all infants born to HBsAG+ mothers follow the CDC protocol to prevent contracting hepatitis B during delivery.
All pregnant women should be tested for hepatitis B with every pregnancy.
Screening Pregnant Women for Hepatitis B Virus (HBV) Infection: Ordering Prenatal Hepatitis B Surface Antigen (HBsAg) Tests from Major Commercial Laboratories (PDF)
Under state law, providers must report HBsAG+ women to the Snohomish Health District within three working days as a notifiable condition.
TO REPORT Monday-Friday 8:00 a.m. to 5:00 p.m. Phone 425.339.5278 or Fax 425.338.8706
Non-urgent after hours, leave a message at 425.339.5235
Perinatal hepatitis B Prevention Program Guidelines (PDF) is available online to assist prenatal providers, pediatricians, parents, hospitals, and local health jurisdictions.
These infants should receive HBIG and dose #1 of hepatitis B vaccine within 12 hours of birth. They should receive dose #2 at 1-2 months, dose #3 at 6 months (not sooner than 24 weeks), and should have post-vaccine serology at 9-12 months (typically at the 12 month well child check). This is an updated CDC protocol as of 10-9-2015.
Post vaccine serology is an HBsAG and an anti-HBs. If the HBsAg is negative and the anti-HBs is positive, the child is immune due to vaccination. Infants that do not respond to the first series should receive a second 3-dose series and be tested 1-2 months after the final dose. If they still show no protection, then they are termed a "non-responder" and are susceptible to hepatitis B infection. Parents/guardians should be counseled about the child receiving HBIG if exposed to someone infected with hepatitis B.
Fewer than 5% of person who receive 6 doses of properly administered hepatitis B vaccine fail to respond to the vaccine successfully.